Entry Detail



General Information

Database ID:exR0080662
RNA Name:RPS3
RNA Type:mRNA
Chromosome:chr11
Starnd:+
Coordinate:
Start Site(bp):75399515End Site(bp):75422280
External Links:ENSG00000149273



Disease Information

Disease Name:Fragile X Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D005600
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Fragile X Syndromes//Syndrome, Fragile X//Syndromes, Fragile X//Marker X Syndrome//Marker X Syndromes//Syndrome, Marker X//Syndromes, Marker X//Mental Retardation, X-Linked, Associated With Marxq28//X-Linked Mental Retardation and Macroorchidism//X Linked Mental Retardation and Macroorchidism//Fragile X Mental Retardation Syndrome//Martin-Bell Syndrome//Martin Bell Syndrome//Syndrome, Martin-Bell//Fra(X) Syndrome//FRAXE Syndrome//FRAXE Syndromes//Syndrome, FRAXE//Syndromes, FRAXE//Mental Retardation, X-Linked, Associated With Fragile Site Fraxe//Fragile X-F Mental Retardation Syndrome//Mar (X) Syndrome//FRAXA Syndrome//FRAXA Syndromes//Syndrome, FRAXA//Syndromes, FRAXA



Expression Detail

GEO ID:GSE83556
Description:Global transcriptome dysregulation in second trimester fetuses with FMR1 expansions
Experimental Design:Disease vs Control
Case Disease Type:Fragile X Syndrome
Case Disease SubType:NA
Case Sample:Fragile X Syndrome
Control Sample:Normal
Number of Case:22
Number of Control:18
Number of Samples:40





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
AL022238.4
chr22
40346529
40410054
+
ADSL
chr22
40346500
40390463
+
AC007192.1
chr19
18153158
18178117
+
ADAR
chr1
154582057
154628013
-
ADNP
chr20
50888916
50931437
-
AK4
chr1
65147549
65232145
+
ADPGK
chr15
72751369
72785846
-
AL136454.1
chr1
192716132
192716653
+
ACIN1
chr14
23058564
23095614
-
ACBD5
chr10
27195214
27242130
-
AL928654.3
chr14
105487199
105492267
+
AL133352.1
chr10
100505628
100529881
-
ACO2
chr22
41469117
41528989
+
AKAP1
chr17
57085092
57121346
+
ACSL5
chr10
112374018
112428380
+
AC008764.4
chr19
16577642
16660115
-
AC068580.4
chr11
1734821
1763954
-
AHSA1
chr14
77457870
77469472
+
AKAP8L
chr19
15380050
15419141
-
ABCF2
chr7
151207837
151227166
-
AGPAT1
chr6
32168212
32178096
-
ADH5
chr4
99070978
99088801
-
ACTB
chr7
5527148
5563784
-
AC002985.1
chr19
18907013
18934397
-
AC004832.3
chr22
30409255
30428990
+
ABCG2
chr4
88090150
88231628
-
AK2
chr1
33007940
33080996
-
AGRN
chr1
1020120
1056118
+
ADORA2A
chr22
24417879
24442357
+
AKNA
chr9
114334156
114394405
-
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-92a-3p
chrX
134169544
134169565
-
hsa-miR-155-5p
chr21
25573983
25574006
+
hsa-miR-3654
chr7
133034860
133034878
-
hsa-miR-4485-3p
chr11
10508277
10508296
-
hsa-miR-6728-3p
chr1
8866502
8866522
-
hsa-miR-6793-3p
chr19
10829016
10829035
+
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC004865.2
chr1
35569813
35577729
-
AC005899.4
chr17
32328441
32329395
+
AC007952.4
chr17
19112000
19112636
-
AC009052.1
chr16
57461055
57462737
+
AC016026.1
chr22
17787652
17811497
-
AC016876.2
chr17
7581964
7584086
-
AC018521.1
chr17
47945424
47981736
+
AC019069.1
chr2
74832655
74833987
-
AC022182.2
chr8
60965802
60967775
-
AC023509.1
chr12
53441741
53467528
+
AC026401.3
chr16
15701237
15702118
+
AC067852.2
chr17
42552436
42554748
-
AC069281.2
chr7
100572232
100578700
-
AC079354.3
chr2
202137570
202149627
-
AC103691.1
chr15
64950916
64951435
-
AC106864.1
chr4
112693047
112706810
-
AC108134.2
chr16
3156736
3157483
-
AC116407.2
chr17
32127595
32128454
+
AC139149.1
chr17
81514047
81527776
+
AC139768.1
chr12
51201684
51202581
-
AC245014.3
chr1
145281116
145281462
+
AC245033.4
chr15
82533175
82540008
-
AC245884.11
chr19
54308915
54337168
-
AD000090.1
chr19
35557956
35581954
+
AL022311.1
chr22
37876148
37895563
+
AL132780.1
chr14
22929607
22956374
+
AL137230.2
chr14
89628921
89642671
-
Display:



Experiment Detail

GEO ID:GSE83556
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:RNA was extracted from 5-15 mL amniotic fluid supernatant (centrifugation at 350g, 4C, 10, min).
RNA Extract protocol:All samples were processed using the Qiagen Circulating Nucleic Acid kit with an on-column DNase digestion step to remove genomic DNA. The RNA was then purified and concentrated with the RNeasy MinElute Clean up kit and eluted in RNasefree water.
RNA library preparation protocol:RNA was converted to cDNA and amplified using the Ovation Pico WTA kit V2 and then purified with the QIAquick PCR Purification kit. Samples were labeled using the Encore Biotin Module (NuGEN, San Carlos, CA)Samples were labeled using the Encore Biotin Module (NuGEN, San Carlos, CA).



Reference

PMID:NA
Title:NA
Author:NA
Journal:NA
Description:NA